Immunogenicity of a three-dose primary series of mRNA COVID-19 vaccines in patients with lymphoid malignancies

Sherman, A. C.A. C.ShermanCrombie, J. L.J. L.CrombieCHI-AN CHENGDesjardins, M.M.DesjardinsZhou, G.G.ZhouOmetoruwa, O.O.OmetoruwaRooks, R.R.RooksSenussi, Y.Y.SenussiMcDonough, M.M.McDonoughGuerrero, L. I.L. I.GuerreroKupelian, J.J.KupelianDoss-Gollin, S.S.Doss-GollinSmolen, K. K.K. K.Smolenvan Haren, S. D.S. D.van HarenArmand, P.P.ArmandLevy, O.O.LevyWalt, D. R.D. R.WaltBaden, L. R.L. R.BadenIssa, N. C.N. C.Issa2022-08-302022-08-30202223288957https://scholars.lib.ntu.edu.tw/handle/123456789/617419[SDGs]SDG3Immunogenicity of a three-dose primary series of mRNA COVID-19 vaccines in patients with lymphoid malignanciesjournal article10.1093/ofid/ofac417